Covalon Technologies

Covalon Technologies Ltd. (Covalon) is a medical device and biotechnology commercialization company. The Company is engaged in the business of developing, licensing and selling medical technologies. The Company operates in two segments: Advanced Wound Care and Specialized Medical Device Coatings. Its offices and laboratories are located in Mississauga, Ontario, Canada. Covalon sells its technologies to medical companies and distributors. Covalon’s antimicrobial technologies can be used for applications in areas, such as medical device coatings, wound care products, polymer mixes for extrusion, skin sanitizers, surface sanitizers, cosmetics, consumer products, veterinary applications, and others. Its products include ColActive, ColActive Ag, ColActive Plus, ColActive Plus Ag and CovaClear Ag. The Company’s wholly owned subsidiaries include Covalon Technologies Inc. and COV Healthcare Innovations Corp.

Brent Ashton

CEO

1 past transactions

AquaGuard

Acquisition in 2018
AquaGuard is the only moisture barrier product line made in the United States at an FDA-registered facility. Certified to ISO 13485: 2003 standards for medical devices, AquaGuard adheres to Good Manufacturing Practices (GMP) to ensure the highest levels of product safety and quality.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.